What is Summit Diagnostics?
Summit Diagnostics is a provider of comprehensive, high-quality testing solutions, specializing in urine and oral fluid drug tests, alcohol saliva tests, COVID and flu tests, infectious disease tests, and pregnancy tests. Leveraging over 14 years of industry experience, the company offers modern testing solutions tailored for the post-COVID era, serving a diverse clientele that requires reliable and efficient diagnostic tools. Their commitment to innovation and excellence positions them as a key player in the testing sector.
How much funding has Summit Diagnostics raised?
Summit Diagnostics has raised a total of $454K across 2 funding rounds:
Debt
$150K
Debt
$304K
Debt (2020): $150K with participation from PPP
Debt (2021): $304K led by PPP
Key Investors in Summit Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Summit Diagnostics?
The substantial late-stage funding, characterized by a major strategic investment, positions Summit Diagnostics for accelerated growth and market penetration. This capital infusion is likely to fuel advancements in product development, expansion of distribution channels, and enhancement of operational capabilities. The company's strategic focus on modern testing solutions for the evolving post-COVID landscape suggests a forward-looking approach, aiming to solidify its market leadership and explore new opportunities within the diagnostics industry.
See full Summit Diagnostics company page
